Higher EPA levels and EPA/DHA Ratios Are associated with Lower Cardiovascular Mortality Post-Myocardial Infarction

Area of Science:

• Cardiovascular Research
• Nutritional Biochemistry
• Clinical Medicine

Background:

• The role of omega-3 fatty acids in cardiovascular health is debated.
• Individual fatty acids may have differential prognostic impacts post-acute myocardial infarction (AMI).

Purpose of the Study:

• To investigate the association between plasma fatty acid (FA) levels, specifically eicosapentaenoic acid (EPA) and the EPA/docosahexaenoic acid (DHA) ratio, and one-year cardiovascular (CV) mortality in AMI patients.

Main Methods:

• Prospective study of 572 AMI patients.
• Plasma FA levels measured by gas chromatography-mass spectrometry.
• Cox proportional hazards models used to analyze associations with one-year CV mortality.

Main Results:

• Patients with higher EPA levels and EPA/DHA ratios had significantly lower one-year CV mortality.
• Lower EPA (0.47% vs. 0.73%) and EPA/DHA ratio (0.33 vs. 0.44) were observed in patients who died.
• Multivariate analysis confirmed the EPA/DHA ratio's association with reduced CV mortality, independent of other risk factors.

Conclusions:

• Elevated plasma EPA levels and EPA/DHA ratios are associated with improved cardiovascular outcomes one year post-AMI.
• These findings highlight the potential prognostic value of specific omega-3 fatty acid profiles in AMI survivors.